ECSP982510A - NEW COMPOUNDS - Google Patents
NEW COMPOUNDSInfo
- Publication number
- ECSP982510A ECSP982510A ECSP982510A ECSP982510A EC SP982510 A ECSP982510 A EC SP982510A EC SP982510 A ECSP982510 A EC SP982510A EC SP982510 A ECSP982510 A EC SP982510A
- Authority
- EC
- Ecuador
- Prior art keywords
- 6alkyl
- alkyl
- optionally substituted
- amino
- group
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 5
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 4
- 125000006272 (C3-C7) cycloalkyl group Chemical group 0.000 abstract 3
- 125000000217 alkyl group Chemical group 0.000 abstract 3
- 125000003118 aryl group Chemical group 0.000 abstract 3
- -1 cyano, carboxy Chemical group 0.000 abstract 3
- 229910052739 hydrogen Inorganic materials 0.000 abstract 3
- 239000001257 hydrogen Substances 0.000 abstract 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 3
- 125000004454 (C1-C6) alkoxycarbonyl group Chemical group 0.000 abstract 2
- 125000004890 (C1-C6) alkylamino group Chemical group 0.000 abstract 2
- 125000006615 aromatic heterocyclic group Chemical group 0.000 abstract 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 2
- 229910052757 nitrogen Inorganic materials 0.000 abstract 2
- 125000006705 (C5-C7) cycloalkyl group Chemical group 0.000 abstract 1
- 125000004423 acyloxy group Chemical group 0.000 abstract 1
- 125000003342 alkenyl group Chemical group 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 abstract 1
- 229910052799 carbon Inorganic materials 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 125000005518 carboxamido group Chemical group 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 125000001072 heteroaryl group Chemical group 0.000 abstract 1
- 125000005842 heteroatom Chemical group 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
- 125000000547 substituted alkyl group Chemical group 0.000 abstract 1
- 125000005420 sulfonamido group Chemical group S(=O)(=O)(N*)* 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Un compuesto o un solvato o una sal del mismo de fórmula (I) (gráfico), en la que Ar es un grupo arilo o cicloalcadienilo C5-7 opcionalmente sustituido, o un grupo cicloalquilo C5-7 o un grupo heterocíclico aromático de anillo único o condensado opcionalmente sustituido; R es alquilo C1-6, cicloalquilo C3-7, cicloalquilo C3-7, alquilo, fenilo o fenil-alquilo C1-6 opcionalmente sustituido, un anillo heteroaromático de cinco miembros, opcionalmente sustituido, que comprende hasta cuatro heteroátmos seleccionados entre O y N, hidroxi-alquilo C1-6, amino-alquilo C1-6-carbonilo, carboxi, alcoxi C1-6 carbonilo, alcoxi C1-6-carbonil-alquilo C1-6, aminocarbonilo, halógeno-alquilo C1-6; o R es un grupo -(CH2)p-en que P es 2 ó 3, cuyo grupo forma un anillo con un átomo de carbono de Ar. R1 representa hidrógeno o hasta cuatro sustituyentes opcionales seleccionados entre la lista que consta de; alquilo C1-6, alquenilo C1-6, arilo, alcoxi C1-6, hidroxi, halógeno, nitro, ciano, carboxi, carboxamido, sulfonamido, alcoxi C1-6-carbonilo, trifluorometido, aciloxi, oftalimido, amino o mono-y di-alquil C1-6-amino R2 representa un resto -(CH2)n -NY1 Y2 en que n es un número entero en el margen de 1 a 9, Y1 es Y2 se seleccionan independientemente entre hidrógeno, alquilo C1-6; alquilo C1-6 sustituido con hidroxi, alquil C1-6 amino o bis (alquil C1-6-amino; alquenilo C1-6; arilo o aril-alquilo C1-6 o Y1 e Y2 conjuntamente con el átomo de nitrógeno al que estan unidos, representan un grupo heterociclico simple o condensado enlazado en N y opcionalmente sustituído; R3 es alquilo C1-6 ramificado o lineal, cicloalquilo C3-7, ciclolaquilquilo C4-7, arilo opcionalmente sustituido, o un grupo heterocíclico aromático de anillo simple o condensado, opcionalmente sustituido, y R4 representa hidrógeno o alquilo C1-C6; una composición farmacéutica que comprende dicho compuesto, un procedimiento para preapra dicho compuesto y el uso de dicho compuesto en medicina.A compound or solvate or salt thereof of formula (I) (graph), wherein Ar is an optionally substituted C5-7 cycloalkadyl or aryl group, or a C5-7 cycloalkyl group or a single ring aromatic heterocyclic group or optionally substituted condensate; R is C 1-6 alkyl, C 3-7 cycloalkyl, C 3-7 cycloalkyl, optionally substituted alkyl, phenyl or phenyl-C 1-6 alkyl, an optionally substituted five-membered heteroaromatic ring comprising up to four heteroatoms selected from O and N , hydroxy-C1-6alkyl, amino-C1-6alkyl-carbonyl, carboxy, C1-6alkoxycarbonyl, C1-6alkoxy-carbonyl-C1-6alkyl, aminocarbonyl, halogen-C1-6alkyl; or R is a group - (CH2) p-in which P is 2 or 3, the group of which forms a ring with a carbon atom of Ar. R1 represents hydrogen or up to four optional substituents selected from the list consisting of; C 1-6 alkyl, C 1-6 alkenyl, aryl, C 1-6 alkoxy, hydroxy, halogen, nitro, cyano, carboxy, carboxamido, sulfonamido, C 1-6 alkoxy-carbonyl, trifluoromethido, acyloxy, ophthalimido, amino or mono-and di -C1-6alkyl-amino R2 represents a residue - (CH2) n -NY1 Y2 where n is an integer in the range of 1 to 9, Y1 is Y2 are independently selected from hydrogen, C1-6 alkyl; C1-6alkyl substituted with hydroxy, C1-6alkyl amino or bis (C1-6alkyl-amino; C1-6alkenyl; aryl or aryl-C1-6alkyl or Y1 and Y2 together with the nitrogen atom to which they are attached , represent an optionally substituted and N-linked fused or simple heterocyclic group; R3 is branched or linear C1-6 alkyl, C3-7 cycloalkyl, C4-7 cyclolakyl, optionally substituted or fused aromatic heterocyclic group, optionally substituted, and R4 represents hydrogen or C1-C6-alkyl, a pharmaceutical composition comprising said compound, a method for pre-preparing said compound and the use of said compound in medicine.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP982510 ECSP982510A (en) | 1998-05-21 | 1998-05-21 | NEW COMPOUNDS |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP982510 ECSP982510A (en) | 1998-05-21 | 1998-05-21 | NEW COMPOUNDS |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP982510A true ECSP982510A (en) | 1999-04-13 |
Family
ID=42043431
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECSP982510 ECSP982510A (en) | 1998-05-21 | 1998-05-21 | NEW COMPOUNDS |
Country Status (1)
| Country | Link |
|---|---|
| EC (1) | ECSP982510A (en) |
-
1998
- 1998-05-21 EC ECSP982510 patent/ECSP982510A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR021354A1 (en) | PROCEDURE FOR THE PREPARATION OF A QUINOLINE DERIVATIVE COMPOUND AND A PROCEDURE TO PREPARE A PHARMACEUTICAL COMPOSITION | |
| CO4950515A1 (en) | NEW DERIVATIVES OF QUINOLINE FOR MEDICINAL USE | |
| AR004735A1 (en) | CHINOLEIN 4-AMIDO SUBSTITUTED, A PROCEDURE FOR ITS PREPARATION, A PHARMACEUTICAL COMPOSITION THAT CONTAINS THEM AND THE USE OF THE SAME FOR THE PREPARATION OF A MEDICINAL PRODUCT. | |
| UY26727A1 (en) | USEFUL TROPANIC DERIVATIVES IN THERAPY | |
| AR038536A1 (en) | N-ARIL-2-OXAZOLIDINONA-5- CARBOXAMIDS AND ITS DERIVATIVES | |
| CO5670367A2 (en) | PHENOXYACETIC ACID DERIVATIVES | |
| CL2012000999A1 (en) | Substituted pyrazolospiroketone derivative compounds, acetyl-coa carboxylase inhibitors; pharmaceutical composition comprising them; use to treat or delay the progression or onset of type 2 diabetes, non-alcoholic fatty liver (hgna), or hepatic insulin resistance. | |
| EA200200942A1 (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING DERIVATIVES 3-AMINOAZETIDINE, NEW DERIVATIVES AND METHOD FOR THEIR PREPARATION | |
| AR004706A1 (en) | A COMPOUND DERIVED FROM BENZOXAZINE AND PIRIDO-OXAZINA USEFUL AS ANTIMICROBIALS, PHARMACEUTICAL COMPOSITION THAT CONTAIN IT, A METHOD TO PREPARE SUCH COMPOUNDS AND INTERMEDIARIES USEFUL FOR SUCH METHOD. | |
| ATE380818T1 (en) | PIPERAZINE-SUBSTITUTED ARYL-BENZODIAZEPINES AND THEIR USE AS DOPAMINE RECEPTOR ANTAGONISTS FOR THE TREATMENT OF PSYCHOSIS | |
| ES2188957T3 (en) | N- (4- (HETEROARILMETIL) FENIL) -HETEROARILAMINAS. | |
| CO5011090A1 (en) | DERIVATIVES OF ACIL-PIPERAZINIL-PIRIMIDINAS, PROCEDURE FOR THE PREPARATION AND PHARMACEUTICAL COMPOSITIONS OF THE SAME | |
| PE20040907A1 (en) | ANILINOPYRAZOLE DERIVATIVES | |
| AR027744A1 (en) | USEFUL DIFENILIC ETER COMPOUNDS IN THERAPY | |
| UY27803A1 (en) | DERIVATIVES OF BENZOXAZINE AND USES OF THE SAME. | |
| EA200300927A1 (en) | A NEW METHOD OF INDUSTRIAL SYNTHESIS OF TETROSETTED ETHERS 5- [BIS (PHYCH) AND-3-TIOPHENCARBONIC ACID AND APPLICATION FOR THE SYNTHESIS OF BATHELETHYLETHYLETCHENKARBONOVOI ACID AND APPLICATION FOR SYNTHESIS | |
| GB9825554D0 (en) | Novel Compounds | |
| PE20250849A1 (en) | NOVEL 7-SUBSTITUTED INDOLE SULFONAMIDE DERIVATIVES | |
| AR037459A1 (en) | ANTAGONISTS VI OF THE CCR-3 RECEIVER | |
| PY0435702A (en) | FUNGICIDAL MIXTURES BASED ON CARBAMATE DERIVATIVES AND INSECTICIDES | |
| HRP20070286T3 (en) | Substituted diketopiperazines and their use as oxytocyn antagonists | |
| CO5680413A2 (en) | AMINO ACIDS WITH AFFINITY FOR C2 DELTA PROTEIN | |
| AR015445A1 (en) | METHOD FOR PREPARING A COMPOUND DERIVED FROM QUINOLINA, SUCH COMPOUNDS AND INTERMEDIATE COMPOUNDS | |
| ECSP982510A (en) | NEW COMPOUNDS | |
| AR057464A1 (en) | PROCEDURE FOR THE PREPARATION OF SULFONAMIDE DERIVATIVES |